Related Experiment Video
Updated: Jun 14, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Phenylketonuria management from an European perspective: a commentary
1Beatrix Children's Hospital, University Medical Center of Groningen, University of Groningen, Groningen, The Netherlands. f.j.van.spronsen@bkk.umcg.nl
Abstract:
Phenylketonuria is discussed from an European perspective, addressing the need of common definitions of terms commonly used, the need of a world-wide guideline on the diagnosis and treatment of phenylketonuria, the differences between existing European guidelines, and day-to-day care, further directives for the near future, and changing the concept from compliance to concordance, in which patients have a more clearly defined responsibility.
Related Concept Videos
Inborn Errors of Metabolism
Chronic Kidney Disease III: Interprofessional Care
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Chronic Kidney Disease IV: Nursing Management
